Open this publication in new window or tab >>Show others...
2024 (English)In: Small, ISSN 1613-6810, E-ISSN 1613-6829, Vol. 20, no 13, article id 2308621Article in journal (Refereed) Published
Abstract [en]
Neuropeptide Y (NPY), as one of the most abundant neuropeptides known, is widely distributed in the central and peripheral nervous system. However, most of the reported NPY-mimetic peptides are hard to cross the blood-brain barrier, target glioma mitochondria, and achieve self-assembly nanostructure in situ. Here, based on the α-helix structure of the novel chiral NPY-mimetic peptides D/LNPY(14), a Y-shaped peptide is designed with the sequences that can be recognized by enterokinase and achieved nanofibers conversion in glioma cell mitochondria. Coupling the Y-shaped NPY-mimetic peptide with the NIR-II fluorophore IR1048, a red-shifting of the fluorescence spectrum beyond 1300 nm is achieved through self-assembly. After the self-assembly in glioma mitochondria, the formed nanofibers can promote intracellular mitochondrial ROS production and extend the NIR-II fluorescence imaging time to at least 7 days in vivo. This work for the first time endows the self-assembly of α-helical-based chiral NPY-mimetic peptides, providing a novel strategy for glioma subcellular regulation enhanced antitumor treatment guided by NIR-II fluorescence imaging.
Place, publisher, year, edition, pages
John Wiley & Sons, 2024
Keywords
D-peptide ligand, neuropeptide Y, NIR-II imaging, self-assembly, Y-1 receptor
National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:uu:diva-529848 (URN)10.1002/smll.202308621 (DOI)001126750800001 ()38109130 (PubMedID)
2024-06-052024-06-052025-02-20Bibliographically approved